Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer

Episode 1 September 06, 2021 00:21:52
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer
COR2ED Medical Education
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer

Sep 06 2021 | 00:21:52

/

Show Notes

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs), in particular VEGFR-TKIs in patients with radioactive iodine refractory differentiated thyroid cancer (DTC).

In this podcast, the two experts discuss key trials (SELECT, DECISION and COSMIC-311) and efficacy parameters of the current VEGFR-TKIs (lenvatinib, sorafenib and cabozantinib), how to manage toxicity whilst trying to optimise treatment outcomes and preserving always patients’ quality of life. They also discuss treatment strategies, when to start systemic treatment, which drug should be used first and how to sequence therapies. To close the podcast they take a look at ongoing clinical trials with other treatments in development for DTC.

Other Episodes

Episode 1

November 30, 2021 00:20:49
Episode Cover

The role of VEGFR-TKIs in the treatment of advanced RCC alone or in combination

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Prof. Georg Hutterer, a Urologist from the Medical University of...

Listen

Episode 1

August 17, 2022 00:29:42
Episode Cover

Role of immunotherapy beyond advanced HCC

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional...

Listen

Episode 1

September 23, 2021 00:18:01
Episode Cover

Diagnosis and treatment of TRK fusion-positive GI cancers

In this podcast, NTRK CONNECT members Prof Frédérique Penault-Llorca (University of Clermont-Ferrand, France) and Prof Andrea Sartore-Bianchi (Niguarda Cancer Centre, Milan, Italy) provide both...

Listen